Center for Scientific Review; Notice of Closed Meetings
Published Date: 2/10/2026
Notice
Summary
The Center for Scientific Review is holding several closed virtual meetings in March 2026 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide who gets funding for cool science projects. If you’re involved in neuroscience, cancer nanotech, or nerve disease research, these reviews could impact your funding timeline and opportunities.
Analyzed Economic Effects
2 provisions identified: 1 benefits, 0 costs, 1 mixed.
Closed virtual grant review meetings
The NIH Center for Scientific Review will hold closed virtual meetings on March 10-11, March 12-13, and March 13, 2026 to review and evaluate grant applications for study sections including Neurotoxicology and Alcohol, Cancer Nanotechnology, Guillain-Barré Syndrome/Chronic Inflammatory Demyelinating Polyneuropathy (GBS/CIDP), and Cell Structure and Function. If you are involved in those research areas, these reviews will affect decisions about who receives NIH research funding and could change your funding timeline or opportunities.
Applicant privacy and trade-secret protection
The meetings are closed to the public under Title 5 U.S.C. sections 552b(c)(4) and 552b(c)(6) to protect confidential trade secrets, patentable material, commercial property, and personal information in grant applications. This protects applicants' confidential and personal data during the March 2026 virtual review meetings.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-06501 — Government-Owned Inventions; Availability for Licensing
The National Institutes of Health is offering a cool new invention—special human antibodies that can fight certain cancers and autoimmune diseases—for companies to license and develop into treatments. This means businesses can jump on this opportunity to create powerful new medicines using government-backed research. Interested parties should act soon and may need to sign agreements to get full details.
2026-06283 — Prospective Grant of an Exclusive Patent License: Pigment Epithelium-Derived Factor (PEDF) Peptides and Use for Treating Retinal Degeneration
The National Eye Institute plans to give Perpetual Biosciences, Inc. an exclusive license to use special PEDF peptides to treat eye diseases that cause vision loss. This means the company will have the sole right to develop and sell this promising treatment, potentially helping millions with retinal degeneration. If you want to comment or apply for a license, act fast—submissions close April 16, 2026!
2026-05957 — Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding several closed virtual meetings in April 2026 to review and decide on important research grant applications. These meetings affect scientists seeking funding in areas like neuroscience, cancer, and liver disease. No public access is allowed to protect private info and trade secrets, and these reviews help decide where millions in research money will go.
2026-05672 — National Institute on Deafness and Other Communication Disorders; Notice of Closed Meetings
The National Institute on Deafness and Other Communication Disorders is holding two closed meetings in late April and early May 2026 to review grant applications and evaluate researchers’ qualifications. These meetings affect scientists seeking funding and help ensure top-notch research gets supported. No public access means privacy is protected, and the process keeps the money flowing to the best projects on time.
2026-05673 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings on April 17, 2026, to review and evaluate important grant applications in health and science fields. These meetings protect private info and trade secrets while deciding who gets funding. Researchers and organizations applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
2026-05738 — Submission for OMB Review; 30-Day Comment Request; National Institutes of Health (NIH) Loan Repayment Programs, (Office of the Director)
The NIH is asking for a 30-day public comment on extending its Loan Repayment Programs that help doctors and scientists pay off their student loans while they do important health research. This extension keeps the program running smoothly with no big changes, and comments are due by April 23, 2026. If you’re a researcher with student loans, this program could save you money while you help improve health!
Previous / Next Documents
Previous: 2026-02542 — Information Collection: Invoice Submissions by Contractors for NRC Contracts/Orders
The Nuclear Regulatory Commission is renewing its rules for how contractors send in invoices for NRC contracts. If you work with the NRC, you’ll want to check the updated process and share your thoughts by March 12, 2026. This keeps payments smooth and on time, with no new costs expected.
Next: 2026-02544 — National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting
The National Institute of Allergy and Infectious Diseases (NIAID) is holding a private meeting from June 8-10, 2026, to review the skills and work of its researchers. This closed meeting affects NIAID staff and helps ensure top-notch science without sharing personal details publicly. No money changes are involved, but the meeting keeps research quality sharp and on track.
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in